...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Trying to get my head around this

To avoid future confusion, I edited the fast facts on the hub home page and deleted the "zzxy" ticker symbol so that it is blank now.  An exchange must be listed and can't be left blank, so I Ieft that as "OTCBB". Just a placeholder, nothing more. 

BearDownAZ 

Share
New Message
Please login to post a reply